Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States

Clin Infect Dis. 2023 Jun 8;76(11):2038-2039. doi: 10.1093/cid/ciad135.

Authors

Anne J Gonzales-Luna¹, Chetna Dureja², Taryn A Eubank¹, Kevin W Garey¹, Julian G Hurdle²

Affiliations

¹ Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, University of Houston, Houston, Texas, USA.
² Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Clostridioides difficile*
Drug Resistance, Bacterial
Humans
United States / epidemiology

Substances

Anti-Bacterial Agents

Grants and funding